Digital Implementation Summit · 2026
Digital Implementation Summit 2026: From Clinical Trials to Clinical Use
Nov 3, 2026
Pfizer Innovation Research Lab · Cambridge, MA · In person
The 9th annual Digital Implementation Summit, From Clinical Trials to Clinical Use: Digital Measures in Clinical Research, returns to Pfizer in Cambridge, MA. It focuses on ways for life sciences to take advantage of new opportunities within digital health and digital measurement, and how these new data can supplement existing collection strategies to drive research forward, getting validated digital measures and digital health tools (DHTs) into the hands of patients, their physicians and caregivers.
The event brings together 30+ speakers and 180+ senior-level pharma, clinical trials, technology and digital health executives to learn how digital health measurement tools are created, validated, scaled and deployed in life sciences to improve data quality and patient experience and accelerate drug development and patient care. For 2026 it is co-created and led by Pfizer and Johnson & Johnson Innovative Medicine.
2026 core themes:
1. Pathways to Value Creation from Investment in Digital Measures
2. Burgeoning Applications of Digital Measures in Clinical Development: Opportunities around Stratification, Classification & Label Expansion
3. Looking Towards the Future of Integrated Multimodal Biomarkers in Clinical Trials
4. Considerations From Discovery to Development: Managing Expectations, Key Learnings and getting to the Finish Line
- Venue
- Pfizer Innovation Research Lab
- Program
- 24 sessions
- 33 speakers
- Organizer
- PanAgora Pharma
Agenda
Tue, Nov 3
-
8:00 AM
60 min
Networking
Registration, Coffee and Conversation
-
9:00 AM
10 min
Other
Opening Remarks from Conference Chairs
Carrie A. Northcott, Pfizer Inc Charmaine Demanuele, Pfizer R&D Phil Murphy, Johnson & Johnson Innovative Medicine
-
9:10 AM
5 min
-
9:15 AM
15 min
-
9:30 AM
15 min
Talk
Reassessing Progress in Sensor-Based Digital Measures for Drug Development: Insights from DiMe's Library of Digital Endpoints
Krista Leonard-Corzo, VivoSense Benjamin Vandendriessche, Digital Medicine Society (DiMe)
-
9:45 AM
30 min
Panel
Panel Discussion: Pathways to Value Creation from Investment in Digital Measures
Carrie A. Northcott, Pfizer Inc Kevin Thomas, Boston University Jarjieh Fang, Pfizer Sarah Ernst, Sanofi Thomas Bartlett
-
10:15 AM
35 min
Break
Networking Coffee Break
-
10:50 AM
-
10:50 AM
15 min
-
11:05 AM
15 min
-
11:20 AM
15 min
-
11:35 AM
30 min
Panel
Panel Discussion: Burgeoning Applications of Digital Measures in Clinical Development: Opportunities around Stratification, Classification & Label Expansion
Phil Murphy, Johnson & Johnson Innovative Medicine Daniel Karlin, Definium Therapeutics Seemi Kazmi, Bristol Myers Squibb Matteo Lai, Empatica Bhaskar Dutta, Alexion Pharmaceuticals
-
12:05 PM
55 min
Break
Networking Luncheon
-
1:00 PM
5 min
Other
Looking Towards Multimodal Digital Biomarkers in Clinical Trials
Srinivasan Vairavan, Johnson & Johnson Innovative Medicine
-
1:05 PM
15 min
Talk
Presentation TBA
-
1:20 PM
15 min
Talk
Insights from Speech, P-tau217, MRI and Tau PET in Preclinical Alzheimer's Disease
Anahita Kyani, Johnson & Johnson Innovative Medicine
-
1:35 PM
15 min
-
1:50 PM
40 min
Panel
Panel Discussion: Integrated Multimodal Digital Biomarkers in Clinical Trials
Srinivasan Vairavan, Johnson & Johnson Innovative Medicine Benjamin Vandendriessche, Digital Medicine Society (DiMe) Derek Hill, UCL Kevin Maresca, Pfizer Junrui Di, Johnson & Johnson Innovative Medicine Francesco Onorati, Takeda
-
2:30 PM
30 min
-
3:00 PM
-
3:00 PM
15 min
-
3:15 PM
25 min
Panel
Panel Discussion: From Recycle to Upcycle: How a cross-industry collaboration to harmonize concepts and terminology on measures of physical activity is advancing a shared standard for digital measures
Jacqueline Thong, DEEP Measures Jared Worful, Bayer Deepak Kumar, Boston University Carrie A. Northcott, Pfizer Inc Javiera Oyarzun, Sanofi
-
3:40 PM
30 min
Panel
Panel Discussion: Managing Regulatory Expectations - Collaborations, Key Learnings and getting to the Finish Line
Ryan Barraco, Johnson & Johnson Innovative Medicine Laura Taraboanta, Pfizer Bola Grace, University College London Kate Lyden, VivoSense
-
4:10 PM
80 min
Networking
Networking Reception
Speakers
-
Pfizer Inc
-
Pfizer R&D
-
Johnson & Johnson Innovative Medicine
-
Pfizer
-
VivoSense
-
Digital Medicine Society (DiMe)
-
Boston University
-
Sanofi
-
Pfizer
-
AbbVie
-
Takeda
-
Pfizer
-
Definium Therapeutics
-
Bristol Myers Squibb
-
Empatica
-
Alexion Pharmaceuticals
-
Johnson & Johnson Innovative Medicine
-
Johnson & Johnson Innovative Medicine
-
University of Oklahoma
-
UCL
-
Pfizer
-
Johnson & Johnson Innovative Medicine
-
Takeda
-
Pfizer
-
DEEP Measures
-
Bayer
-
Boston University
-
Sanofi
-
Johnson & Johnson Innovative Medicine
-
Pfizer
-
University College London
-
VivoSense
Plan your trip
Open in Google Maps(opens in a new tab)
Sponsors
Host
Gold Sponsor
Supporting
- Empatica
- DEEP Measures
- Exponent
- Strados Labs
- Evidation
- Hexoskin
From $1,195
Get tickets(opens in a new tab)